Recently Viewed
Clear All$1.83
As on 02-Apr-2026 12:35EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$98 Mln
Revenue (TTM)
$1 Mln
Net Profit (TTM)
$0 Mln
ROE
-3.4 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
25.1
Industry P/E
54.26
EV/EBITDA
-0
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$-2304.3
Face value
--
Shares outstanding
52,802,604
CFO
$-131.94 Mln
EBITDA
$-164.72 Mln
Net Profit
$-133.59 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Helius Medical Technologies Inc Class A (HSDT)
| -34.6 | 1.1 | -34.6 | -99.4 | -94.2 | -92.2 | -77.3 |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Helius Medical Technologies Inc Class A (HSDT)
| -99.4 | -91.5 | -47.6 | -94.1 | -60.6 | -61.2 | -89.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Helius Medical Technologies Inc Class A (HSDT)
|
1.9 | 98.2 | 0.9 | -370.4 | -39,223.2 | -- | -- | 25.1 |
| 7.8 | 5,176.8 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 0.9 | |
| 36.3 | 5,222.6 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.1 | |
| 25.6 | 3,989.0 | 2,719.5 | 47.0 | 8.4 | 1.6 | 86.6 | 1.3 | |
| 112.2 | 6,098.9 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 8.9 | |
| 75.9 | 4,758.4 | 1,541.6 | 233.6 | 21.6 | 21.4 | 21.4 | 4.5 | |
| 178.5 | 9,411.8 | 1,526.9 | -151.5 | 20.0 | -17.1 | -- | 12.9 | |
| 330.1 | 12,879.6 | 1,403.7 | 177.7 | 14.7 | 13.8 | 72.5 | 9.2 | |
| 117.7 | 6,280.4 | 738.3 | 48.9 | 11.4 | 2.4 | 129.6 | 3.0 | |
| 31.9 | 13,409.8 | 6,178.4 | 626.5 | 13.0 | 11.9 | 22.1 | 2.6 |
Solana Company operates as a listed digital asset treasury. It enhances SOL per share on the commercially viable blockchain for decentralized finance and consumer applications. The company is headquartered in Newtown, Pennsylvania. Address: 642... Newtown Yardley Road, Newtown, PA, United States, 18940 Read more
President, CEO & Director
Mr. Dane Carl Andreeff
President, CEO & Director
Mr. Dane Carl Andreeff
Headquarters
Newtown, PA
Website
The share price of Helius Medical Technologies Inc Class A (HSDT) is $1.83 (NASDAQ) as of 02-Apr-2026 12:35 EDT. Helius Medical Technologies Inc Class A (HSDT) has given a return of -94.17% in the last 3 years.
Since, TTM earnings of Helius Medical Technologies Inc Class A (HSDT) is negative, P/E ratio is not available.
The P/B ratio of Helius Medical Technologies Inc Class A (HSDT) is 25.15 times as on 31-Mar-2026, a 753 premium to its peers’ median range of 2.95 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.01
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
|
2020
|
--
|
--
|
The 52-week high and low of Helius Medical Technologies Inc Class A (HSDT) are Rs 319.35 and Rs 1.61 as of 02-Apr-2026.
Helius Medical Technologies Inc Class A (HSDT) has a market capitalisation of $ 98 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Helius Medical Technologies Inc Class A (HSDT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.